BRIC
View Older Stories View More Recent Stories
-
Brick Street Realty Partners With Side To Grow Its Loyal Client Base
-
IAPMO Supports Passage of Federal Infrastructure Legislation
-
Brickworks Expands North American Footprint with New Design Studio in Baltimore
-
National Association of Chronic Disease Directors Announces Launch of the Center for Advancing Healthy Communities
-
Brickell Biotech Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
MTC, ABAG Leaders Applaud Passage of New Infrastructure Bill
-
Brick by Brick Capital Acquires Historic Four Seasons Island Resort in Pembine, Wisconsin in Partnership with Life House
-
Canada Ranks 10th for Retiree Wellbeing in Natixis Investment Managers’ 2021 Global Retirement Index as Savers Hope for a Miracle
-
BrickBio Announces Rapid V2, eCLIC™, Chemistry and Cytokine External Partner Collaboration
-
The Brooklyn Tower at 9 DeKalb Tops Out--Taking the Crown as Brooklyn's First Supertall Skyscraper
-
Brickell Biotech to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9, 2021
-
Thompson Central Park New York Debuts in Midtown Manhattan
-
Brickell Biotech (BBI) Prices 26.3M Share Offering at $0.38/sh
-
Brickell Biotech Prices Public Offering of Common Stock
-
Brickell Biotech (BBI) Announces Proposed Underwritten Public Offering of Common Stock
-
Brickell Biotech Announces Proposed Underwritten Public Offering of Common Stock
-
Reservoir Signs Singer-Songwriter Madison McFerrin to a Worldwide Admin Deal
-
Webtel.mobi Describes Why the High Debt of G7 Countries is a Likely Barrier to Global CBDC and Digital Currency Adoption
-
Webtel.mobi Describes Why the High Debt of G7 Countries is a Likely Barrier to Global CBDC and Digital Currency Adoption
-
Brickell Biotech (BBI) Achieves Statistical Significance on all Primary, Secondary Endpoints from Both U.S. Phase 3 Pivotal Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis
-
Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints, from Both U.S. Phase 3 Pivotal Clinical Studies of Sofpironium Bromide G
-
Brickell Biotech to Host Key Opinion Leader Webinar on DYRK1A and its Role in Autoimmunity
-
United States Ranks 17th for Retiree Wellbeing in Natixis Investment Managers’ 2021 Global Retirement Index as Savers Hope for a Miracle
-
Ari Lennox Salutes Her Favorite Iconic Divas With New Riveting Video "Pressure"
-
Brickell Biotech to Participate at Upcoming September Conferences
-
DAX welcomes ten new members
-
Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
-
Brickell Biotech (BBI) Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform
-
Brickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform Targeting Autoimmune and Inflammatory Diseases
-
Brickell Biotech Announces Final Patient Completed Second U.S. Phase 3 Pivotal Clinical Study of Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis
-
Brickell Biotech Reports Second Quarter 2021 Financial Results and Provides Corporate Update
-
Senate bill takes first step in recognizing buildings as infrastructure
-
Theo Croker Announces New Album BLK2LIFE || A FUTURE PAST Ft. Wyclef Jean, Ari Lennox, Malaya, Kassa Overall, And More Available September 24 - Preorder Now
-
Brickworks North America Corporation Expands Direct Distribution Network with the Acquisition of The Largest Independent Brick Distributor in the U.S.
-
Brickell Biotech to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12, 2021
-
Crédit Agricole Normandie Seine : fiches descriptives de caisses locales
-
Brickell Biotech Announces Closing of $8.05 Million Bought Deal Offering of Common Stock, Including Full Exercise of the Underwriter’s Option to Purchase Additional Shares
-
Brickson Diamond Joins Gentreo's Board to Generate New Partnerships and Uncover Exceptional Diverse Talent
-
Baker Hughes Company Announces Second Quarter 2021 Results
-
Brickell Biotech Increases Previously Announced Bought Deal Offering of Common Stock to $7.0 Million
-
Brickell Biotech (BBI) Announces $5 Million Bought Deal Offering of Common Stock
-
Brickell Biotech Announces $5.0 Million Bought Deal Offering of Common Stock
-
Brickell Biotech to Participate at William Blair’s Biotech Focus Conference 2021
-
Brickell Biotech Announces Final Patient Completed in First U.S. Phase 3 Pivotal Clinical Study and Patient Enrollment Completed in Second U.S. Phase 3 Pivotal Clinical Study of Sofpironium Bromide Ge
-
Brickell Biotech Announces Initiation of a Phase 1 Study of Sofpironium Bromide Gel in Primary Palmoplantar Hyperhidrosis Patients by its Development Partner, Kaken Pharmaceutical in Japan
-
Black Resilience in Colorado Fund Marks First Year Milestone
-
Black Resilience in Colorado Fund Marks First Year Milestone
-
Brickell Biotech (BBI) Announces Publication of Japan Phase 3 Long-Term Safety and Efficacy Study Results for Sofpironium Bromide Gel, 5% in the Journal of Dermatology
-
Brickell Biotech Announces Publication of Japan Phase 3 Long-Term Safety and Efficacy Study Results for Sofpironium Bromide Gel, 5% (ECCLOCK®) in the Journal of Dermatology
-
Brickworks Opens New North American Supply Center

